Auxin biosynthesis inhibitor

US9259000B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9259000-B2
Application numberUS-201213261726-A
CountryUS
Kind codeB2
Filing dateFeb 28, 2012
Priority dateFeb 28, 2011
Publication dateFeb 16, 2016
Grant dateFeb 16, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An object of the present invention is to provide an auxin biosynthesis inhibitor superior to L-AOPP. The object can be attained by a compound represented by general formula (I): wherein, R 1 to R 5 and X are the same as defined in the specification or a salt or solvate thereof.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound represented by general formula (I): wherein R 1 is chlorophenyl, bromophenyl, biphenyl, phenoxyphenyl, 4-chloro-3-methylphenyl, 4-chloro-2-methylphenyl, dichlorophenyl, 6-methoxy-2-naphthyl, naphthyl or quinolinyl; R 2 is a C 1-6 alkyl group; R 3 and R 4 are each hydrogen, or R 3 is hydrogen and R 4 is acetyl or benzoyl, or R 3 and R 4 together form propan-2-ylidene or R 3 and R 4 , together with a nitrogen atom to which R 3 and R 4 are bound, form phthalimide or succinimide; R 5 is hydrogen; and X is O, or a salt or solvate thereof. 2. The compound according to claim 1 , wherein R 1 is 2-naphthyl, R 2 is methyl, R 3 and R 4 are each hydrogen or R 3 and R 4 , together with a nitrogen atom to which R 3 and R 4 are bound, form phthalimide, R 5 is hydrogen, and X is O. 3. A method for inhibiting biosynthesis of auxin in a plant, comprising applying the compound according to claim 1 to the plant. 4. A method for inhibiting tryptophan aminotransferase in a plant, comprising applying the compound according to claim 1 to the plant. 5. A method for inhibiting tryptophan aminotransferase, comprising bringing the compound according to claim 1 into contact with the tryptophan aminotransferase in vitro. 6. A method for regulating growth of a plant, comprising applying the compound according to claim 1 to the plant. 7. A method for weeding a plant, comprising applying the compound according to claim 1 to the plant.

Assignees

Inventors

Classifications

  • having oxygen atoms of hydroxylamino groups etherified · CPC title

  • with hetero atoms directly attached to the ring nitrogen atom · CPC title

  • having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms · CPC title

  • condensed with carbocyclic rings · CPC title

  • condensed with carbocyclic rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9259000B2 cover?
An object of the present invention is to provide an auxin biosynthesis inhibitor superior to L-AOPP. The object can be attained by a compound represented by general formula (I): wherein, R 1 to R 5 and X are the same as defined in the specification or a salt or solvate thereof.
Who is the assignee on this patent?
Shimada Yukihisa, Kikuzato Ko, Narukawa Megumi, and 4 more
What technology area does this patent fall under?
Primary CPC classification A01N43/60. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).